Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycemic control. - Jain,S.K.; Nagi,D.K.; Slavin,B.M. (Diabet Med, 1993)